Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001103780-17-000001
Filing Date
2017-06-23
Accepted
2017-06-23 16:41:36
Documents
1
Period of Report
2010-01-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 8215
  Complete submission text file 0001103780-17-000001.txt   9689
Mailing Address 1924 BIRKDALE AVE KELOWNA A1 V1P1R7
Business Address
BUNKA CHRISTOPHER (Reporting) CIK: 0001103780 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52138 | Film No.: 17928137

Mailing Address 156 VALLEYVIEW ROAD KELOWNA A1 V1X 3M4
Business Address 156 VALLEYVIEW ROAD KELOWNA A1 V1X 3M4 250-765-6424
Lexaria Bioscience Corp. (Issuer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
SIC: 1000 Metal Mining